Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma

Multidrug resistance in mucoepidermoid carcinoma of the parotid gland – immunohistochemical investigations of P-glycoprotein expression

(2013) Tohru Furusaka et al.   ACTA OTO-LARYNGOLOGICA

Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway

(2013) Sang Hyuk Lee et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma

(2010) Dirk Theile et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy

(2009) Dirk Theile et al.   BIOCHEMICAL PHARMACOLOGY

Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation

(2009) Guido B. van den Broek et al.   INTERNATIONAL JOURNAL OF CANCER

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

(2008) E. T. Morgan et al.   DRUG METABOLISM AND DISPOSITION

Association between multidrug resistance–associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy

(2008) Noppadol Larbcharoensub et al.   HUMAN PATHOLOGY